News & Events

You are here

Asia-Pacific specialist CRO Novotech presented Australia's R&D Refund and Simplified Regulatory Environment as a Gateway to Asia at a Government and industry event in Seoul, South Korea.

30/09/14

NOVOTECH CRO EXPANDS ASIA REGION SERVICES WITH NEW CHINA OFFICE IN SHANGHAI

NOVOTECH CRO EXPANDS ASIA REGION SERVICES WITH NEW CHINA OFFICE IN SHANGHAI

Shanghai, China, 30 September, 2014 | Novotech, Australia’s largest clinical CRO with offices throughout Asia, announced today...

27/06/14

Clinical Trials in Asia – 10 Years on

In 2004, I authored an article entitled “Clinical Trials in Asia: A Promising Picture” on the potential of Asia as a significant contributor to global clinical drug development. The article was published in the Ernst and Young Annual Global...

15/06/14

NOVOTECH CRO ANNOUNCES MOU WITH KOREA DRUG DEVELOPMENT FUND (KDDF) AT DIA 2014

NOVOTECH CRO ANNOUNCES MOU WITH KOREA DRUG DEVELOPMENT FUND (KDDF) AT DIA 2014

San Diego, CA, June 15, 2014 | Novotech, Australia’s largest clinical CRO with offices throughout Asia, has...

10/05/14

Considerations for Asia Pacific clinical trials

As in many other industries, the emerging markets of Asia represent new frontiers for pharmaceutical and biotechnology companies. In recent years the widespread adoption of GCP across the region has meant the industry now is looking to Asia not...

10/03/14

Asian Century and clinical trials: Issues for consideration by biotechnology companies

As with many other industries, there is a prevailing belief that the 21st Century will be the Asian Century when it comes to drug development and the pharmaceutical industry. Already, markets such as China are predicted to overtake the US to...

23/06/13

Australian CRO Novotech announces expanded Asia reach into Hong Kong and Philippines at DIA 2013

Sydney, Australia, 23 June, 2013 – Novotech, Australia’s largest clinical CRO has expanded its Asia reach into Hong Kong and the Philippines, building on its established network which already includes a presence in Singapore, South Korea, Taiwan...

31/05/13

Experienced Australian CRO attains Medidata accreditation to offer enhanced clinical trial services

Media contact:
Susan Fitzpatrick-Napier
DMG
Australia: +61 2 8006 0424
USA: +1650 7985238
EMAIL: susan@dmgpr.com

NOVOTECH...

06/05/13

NOVOTECH CRO ATTRACTS INVESTMENT FOR ASIA CLINICAL TRIAL EXPANSION

Media contact:
Susan Fitzpatrick-Napier
Digital Mantra Group (DMG)
Australia: +61 2 8006 0424
USA: +1650 7985238
EMAIL:...

04/02/13

Alchemia Recruits Full Patient Quota to Pivotal Phase III HAIrinotecan Trial in Metastatic Colorectal Cancer

Brisbane-based drug discovery and development company Alchemia Limited (ASX: ACL) has recruited the 390th patient to its pivotal Phase III clinical trial
of the Company’s lead cancer drug, HA-Irinotecan, as per its study protocol.

07/12/11

The Road Less Travelled – Navigation through the do’s and don’ts of running Oncology studies in Asia Pacific

Clinical trials in the Asia Pacific are increasing exponentially. Numerous sponsors and CROs have accessed this region in recent years to take advantage of high performing, cost effective sites. 

 

Listen to the...

Pages